EphA2 Is a Clinically Relevant Target for Breast Cancer Bone Metastatic Disease

EphA2 receptor tyrosine kinase (RTK) is highly expressed in breast tumor cells across multiple molecular subtypes and correlates with poor patient prognosis. In this study, the potential role of EphA2 in this clinically relevant phenomenon is investigated as metastasis of breast cancer to bone is a...

Full description

Saved in:
Bibliographic Details
Published in:JBMR Plus
Main Authors: Vaught, David B, Merkel, Alyssa R, Lynch, Conor C, Edwards, James, Tantawy, Mohammed Noor, Hilliard, Timothy, Wang, Shan, Peterson, Todd, Johnson, Rachelle W, Sterling, Julie A, Brantley‐Sieders, Dana
Format: Artigo
Language:Inglês
Published: John Wiley & Sons, Inc. 2021
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8046157/
https://ncbi.nlm.nih.gov/pubmed/33869989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbm4.10465
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items